Publicité
Publicité

BLFS

BLFS logo

BioLife Solutions Inc.

24.82
USD
Sponsorisé
-0.13
-0.50%
09 janv., 15:58 UTC -5
Fermé
exchange

Après-marché

24.85

+0.03
+0.10%

BLFS Rapports sur les bénéfices

Ratio de surprise positive

BLFS a dépassé 22 des 40 dernières estimations.

55%

Prochain rapport

Date du prochain rapport
02 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$24.56M
/
-$0.02
Variation implicite de Q3 25 (Revenue/ EPS)
-12.48%
/
-300.00%
Variation implicite de Q4 24 (Revenue/ EPS)
+8.15%
/
-107.69%

BioLife Solutions Inc. earnings per share and revenue

On 06 nov. 2025, BLFS reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 184.03% surprise. Revenue reached 28.07 million, compared to an expected 26.21 million, with a 7.10% difference. The market reacted with a -4.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analystes forecast an EPS of -0.02 USD, with revenue projected to reach 24.56 million USD, implying an baisse of -300.00% EPS, and baisse of -12.48% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08 janv. 2026 Pour Q2 26
Estimation
$0.05
Actuel
$0.10
Surprise
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08 janv. 2026 Pour Q2 26
Estimation
-$0.20
Actuel
-$0.41
Surprise
-100.98%
FAQ
For Q3 2025, BioLife Solutions Inc. reported EPS of $0.01, beating estimates by 184.03%, and revenue of $28.07M, 7.1% above expectations.
The stock price moved down -4.03%, changed from $27.02 before the earnings release to $25.93 the day after.
The next earning report is scheduled for 02 mars 2026.
Based on 12 analystes, BioLife Solutions Inc. is expected to report EPS of -$0.02 and revenue of $24.56M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité